nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—TUBA4A—amyotrophic lateral sclerosis	0.596	1	CbGaD
Cabazitaxel—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.203	1	CbGbCtD
Cabazitaxel—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0373	CcSEcCtD
Cabazitaxel—Paclitaxel—MAPT—amyotrophic lateral sclerosis	0.00233	0.5	CrCbGaD
Cabazitaxel—Docetaxel—MAPT—amyotrophic lateral sclerosis	0.00233	0.5	CrCbGaD
Cabazitaxel—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0303	CcSEcCtD
Cabazitaxel—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0292	CcSEcCtD
Cabazitaxel—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00173	0.027	CcSEcCtD
Cabazitaxel—TUBA4A—hindbrain—amyotrophic lateral sclerosis	0.00164	0.054	CbGeAlD
Cabazitaxel—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0227	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0218	CcSEcCtD
Cabazitaxel—TUBB4A—hindbrain—amyotrophic lateral sclerosis	0.00131	0.0432	CbGeAlD
Cabazitaxel—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0199	CcSEcCtD
Cabazitaxel—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0197	CcSEcCtD
Cabazitaxel—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0179	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0158	CcSEcCtD
Cabazitaxel—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000985	0.0154	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000962	0.015	CcSEcCtD
Cabazitaxel—TUBB8—nervous system—amyotrophic lateral sclerosis	0.000949	0.0313	CbGeAlD
Cabazitaxel—TUBA4A—brainstem—amyotrophic lateral sclerosis	0.000938	0.0309	CbGeAlD
Cabazitaxel—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000914	0.0143	CcSEcCtD
Cabazitaxel—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000914	0.0143	CcSEcCtD
Cabazitaxel—TUBB8—central nervous system—amyotrophic lateral sclerosis	0.000913	0.0301	CbGeAlD
Cabazitaxel—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000894	0.0139	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000878	0.0137	CcSEcCtD
Cabazitaxel—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000875	0.0136	CcSEcCtD
Cabazitaxel—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000869	0.0136	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000866	0.0135	CcSEcCtD
Cabazitaxel—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000851	0.0133	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000848	0.0132	CcSEcCtD
Cabazitaxel—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000837	0.013	CcSEcCtD
Cabazitaxel—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000831	0.013	CcSEcCtD
Cabazitaxel—TUBB4A—embryo—amyotrophic lateral sclerosis	0.000821	0.027	CbGeAlD
Cabazitaxel—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000777	0.0121	CcSEcCtD
Cabazitaxel—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000777	0.0121	CcSEcCtD
Cabazitaxel—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000768	0.012	CcSEcCtD
Cabazitaxel—TUBB4A—brainstem—amyotrophic lateral sclerosis	0.000752	0.0248	CbGeAlD
Cabazitaxel—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000752	0.0117	CcSEcCtD
Cabazitaxel—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000745	0.0116	CcSEcCtD
Cabazitaxel—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0116	CcSEcCtD
Cabazitaxel—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0116	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000726	0.0113	CcSEcCtD
Cabazitaxel—TUBB8—brain—amyotrophic lateral sclerosis	0.000725	0.0239	CbGeAlD
Cabazitaxel—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00072	0.0112	CcSEcCtD
Cabazitaxel—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000707	0.011	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000662	0.0103	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000657	0.0102	CcSEcCtD
Cabazitaxel—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000655	0.0102	CcSEcCtD
Cabazitaxel—TUBA4A—medulla oblongata—amyotrophic lateral sclerosis	0.000654	0.0216	CbGeAlD
Cabazitaxel—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000654	0.0102	CcSEcCtD
Cabazitaxel—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000652	0.0102	CcSEcCtD
Cabazitaxel—TUBB3—nervous system—amyotrophic lateral sclerosis	0.000647	0.0213	CbGeAlD
Cabazitaxel—TUBB4B—embryo—amyotrophic lateral sclerosis	0.00064	0.0211	CbGeAlD
Cabazitaxel—TUBB1—nervous system—amyotrophic lateral sclerosis	0.000633	0.0209	CbGeAlD
Cabazitaxel—TUBB3—central nervous system—amyotrophic lateral sclerosis	0.000623	0.0205	CbGeAlD
Cabazitaxel—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000622	0.0097	CcSEcCtD
Cabazitaxel—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000617	0.00963	CcSEcCtD
Cabazitaxel—TUBB1—central nervous system—amyotrophic lateral sclerosis	0.000609	0.0201	CbGeAlD
Cabazitaxel—TUBB3—cerebellum—amyotrophic lateral sclerosis	0.000609	0.0201	CbGeAlD
Cabazitaxel—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000604	0.00941	CcSEcCtD
Cabazitaxel—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00937	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00935	CcSEcCtD
Cabazitaxel—Chills—Riluzole—amyotrophic lateral sclerosis	0.000597	0.00931	CcSEcCtD
Cabazitaxel—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000594	0.00927	CcSEcCtD
Cabazitaxel—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00917	CcSEcCtD
Cabazitaxel—TUBA4A—spinal cord—amyotrophic lateral sclerosis	0.000583	0.0192	CbGeAlD
Cabazitaxel—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000583	0.00909	CcSEcCtD
Cabazitaxel—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00903	CcSEcCtD
Cabazitaxel—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000567	0.00884	CcSEcCtD
Cabazitaxel—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00056	0.00874	CcSEcCtD
Cabazitaxel—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000557	0.00868	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000537	0.00838	CcSEcCtD
Cabazitaxel—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000535	0.00835	CcSEcCtD
Cabazitaxel—TUBB4A—medulla oblongata—amyotrophic lateral sclerosis	0.000524	0.0173	CbGeAlD
Cabazitaxel—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00814	CcSEcCtD
Cabazitaxel—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00052	0.00811	CcSEcCtD
Cabazitaxel—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00808	CcSEcCtD
Cabazitaxel—TUBB2B—medulla oblongata—amyotrophic lateral sclerosis	0.000507	0.0167	CbGeAlD
Cabazitaxel—Cough—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00788	CcSEcCtD
Cabazitaxel—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0005	0.0078	CcSEcCtD
Cabazitaxel—TUBB3—brain—amyotrophic lateral sclerosis	0.000495	0.0163	CbGeAlD
Cabazitaxel—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00769	CcSEcCtD
Cabazitaxel—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00769	CcSEcCtD
Cabazitaxel—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00769	CcSEcCtD
Cabazitaxel—TUBA4A—nervous system—amyotrophic lateral sclerosis	0.000492	0.0162	CbGeAlD
Cabazitaxel—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00766	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00049	0.00764	CcSEcCtD
Cabazitaxel—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000487	0.0076	CcSEcCtD
Cabazitaxel—TUBB1—brain—amyotrophic lateral sclerosis	0.000484	0.0159	CbGeAlD
Cabazitaxel—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000482	0.00752	CcSEcCtD
Cabazitaxel—TUBB—medulla oblongata—amyotrophic lateral sclerosis	0.00048	0.0158	CbGeAlD
Cabazitaxel—TUBB2A—medulla oblongata—amyotrophic lateral sclerosis	0.000477	0.0157	CbGeAlD
Cabazitaxel—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000477	0.00743	CcSEcCtD
Cabazitaxel—TUBA4A—central nervous system—amyotrophic lateral sclerosis	0.000473	0.0156	CbGeAlD
Cabazitaxel—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000473	0.00737	CcSEcCtD
Cabazitaxel—TUBB6—medulla oblongata—amyotrophic lateral sclerosis	0.000471	0.0155	CbGeAlD
Cabazitaxel—Infection—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00732	CcSEcCtD
Cabazitaxel—TUBB4A—spinal cord—amyotrophic lateral sclerosis	0.000468	0.0154	CbGeAlD
Cabazitaxel—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00723	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000463	0.00722	CcSEcCtD
Cabazitaxel—TUBA4A—cerebellum—amyotrophic lateral sclerosis	0.000463	0.0152	CbGeAlD
Cabazitaxel—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00719	CcSEcCtD
Cabazitaxel—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000459	0.00716	CcSEcCtD
Cabazitaxel—TUBB2B—spinal cord—amyotrophic lateral sclerosis	0.000452	0.0149	CbGeAlD
Cabazitaxel—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00703	CcSEcCtD
Cabazitaxel—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00689	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00672	CcSEcCtD
Cabazitaxel—TUBB—spinal cord—amyotrophic lateral sclerosis	0.000428	0.0141	CbGeAlD
Cabazitaxel—TUBB2A—spinal cord—amyotrophic lateral sclerosis	0.000425	0.014	CbGeAlD
Cabazitaxel—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000424	0.00662	CcSEcCtD
Cabazitaxel—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000421	0.00657	CcSEcCtD
Cabazitaxel—TUBB6—spinal cord—amyotrophic lateral sclerosis	0.00042	0.0138	CbGeAlD
Cabazitaxel—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000416	0.00649	CcSEcCtD
Cabazitaxel—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00641	CcSEcCtD
Cabazitaxel—TUBB4B—medulla oblongata—amyotrophic lateral sclerosis	0.000409	0.0135	CbGeAlD
Cabazitaxel—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00636	CcSEcCtD
Cabazitaxel—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00635	CcSEcCtD
Cabazitaxel—Pain—Riluzole—amyotrophic lateral sclerosis	0.000404	0.0063	CcSEcCtD
Cabazitaxel—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000404	0.0063	CcSEcCtD
Cabazitaxel—TUBB4A—nervous system—amyotrophic lateral sclerosis	0.000394	0.013	CbGeAlD
Cabazitaxel—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000389	0.00607	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00603	CcSEcCtD
Cabazitaxel—TUBB2B—nervous system—amyotrophic lateral sclerosis	0.000381	0.0125	CbGeAlD
Cabazitaxel—TUBB4A—central nervous system—amyotrophic lateral sclerosis	0.000379	0.0125	CbGeAlD
Cabazitaxel—TUBA4A—brain—amyotrophic lateral sclerosis	0.000376	0.0124	CbGeAlD
Cabazitaxel—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00583	CcSEcCtD
Cabazitaxel—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00583	CcSEcCtD
Cabazitaxel—TUBB4A—cerebellum—amyotrophic lateral sclerosis	0.000371	0.0122	CbGeAlD
Cabazitaxel—TUBB2B—central nervous system—amyotrophic lateral sclerosis	0.000367	0.0121	CbGeAlD
Cabazitaxel—TUBB4B—spinal cord—amyotrophic lateral sclerosis	0.000365	0.012	CbGeAlD
Cabazitaxel—TUBB2A—nervous system—amyotrophic lateral sclerosis	0.000358	0.0118	CbGeAlD
Cabazitaxel—TUBB2B—cerebellum—amyotrophic lateral sclerosis	0.000358	0.0118	CbGeAlD
Cabazitaxel—TUBB6—nervous system—amyotrophic lateral sclerosis	0.000354	0.0117	CbGeAlD
Cabazitaxel—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00543	CcSEcCtD
Cabazitaxel—TUBB2A—central nervous system—amyotrophic lateral sclerosis	0.000345	0.0114	CbGeAlD
Cabazitaxel—TUBB6—central nervous system—amyotrophic lateral sclerosis	0.00034	0.0112	CbGeAlD
Cabazitaxel—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00529	CcSEcCtD
Cabazitaxel—TUBB—cerebellum—amyotrophic lateral sclerosis	0.000339	0.0112	CbGeAlD
Cabazitaxel—TUBB2A—cerebellum—amyotrophic lateral sclerosis	0.000337	0.0111	CbGeAlD
Cabazitaxel—TUBB6—cerebellum—amyotrophic lateral sclerosis	0.000333	0.011	CbGeAlD
Cabazitaxel—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000323	0.00504	CcSEcCtD
Cabazitaxel—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00487	CcSEcCtD
Cabazitaxel—TUBB4B—nervous system—amyotrophic lateral sclerosis	0.000307	0.0101	CbGeAlD
Cabazitaxel—TUBB4A—brain—amyotrophic lateral sclerosis	0.000301	0.00992	CbGeAlD
Cabazitaxel—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000301	0.00469	CcSEcCtD
Cabazitaxel—Headache—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00462	CcSEcCtD
Cabazitaxel—TUBB4B—central nervous system—amyotrophic lateral sclerosis	0.000296	0.00975	CbGeAlD
Cabazitaxel—TUBB2B—brain—amyotrophic lateral sclerosis	0.000291	0.00959	CbGeAlD
Cabazitaxel—TUBB4B—cerebellum—amyotrophic lateral sclerosis	0.000289	0.00953	CbGeAlD
Cabazitaxel—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000281	0.00438	CcSEcCtD
Cabazitaxel—TUBB—brain—amyotrophic lateral sclerosis	0.000275	0.00908	CbGeAlD
Cabazitaxel—TUBB2A—brain—amyotrophic lateral sclerosis	0.000274	0.00903	CbGeAlD
Cabazitaxel—TUBB6—brain—amyotrophic lateral sclerosis	0.00027	0.00891	CbGeAlD
Cabazitaxel—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000241	0.00795	CbGeAlD
Cabazitaxel—TUBB4B—brain—amyotrophic lateral sclerosis	0.000235	0.00774	CbGeAlD
Cabazitaxel—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000215	0.00709	CbGeAlD
Cabazitaxel—ABCB1—embryo—amyotrophic lateral sclerosis	0.000186	0.00613	CbGeAlD
Cabazitaxel—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000171	0.00562	CbGeAlD
Cabazitaxel—CYP2C8—brain—amyotrophic lateral sclerosis	0.000142	0.0047	CbGeAlD
Cabazitaxel—ABCG2—brain—amyotrophic lateral sclerosis	0.000139	0.00457	CbGeAlD
Cabazitaxel—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000126	0.00416	CbGeAlD
Cabazitaxel—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000122	0.00401	CbGeAlD
Cabazitaxel—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000119	0.00392	CbGeAlD
Cabazitaxel—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000106	0.0035	CbGeAlD
Cabazitaxel—ABCB1—nervous system—amyotrophic lateral sclerosis	8.94e-05	0.00295	CbGeAlD
Cabazitaxel—ABCB1—central nervous system—amyotrophic lateral sclerosis	8.6e-05	0.00284	CbGeAlD
Cabazitaxel—ABCB1—cerebellum—amyotrophic lateral sclerosis	8.41e-05	0.00277	CbGeAlD
Cabazitaxel—ABCB1—brain—amyotrophic lateral sclerosis	6.83e-05	0.00225	CbGeAlD
Cabazitaxel—TUBB—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	6.81e-05	0.00067	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	6.79e-05	0.000668	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	6.79e-05	0.000668	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.77e-05	0.000666	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	6.74e-05	0.000663	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	6.74e-05	0.000663	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	6.68e-05	0.000657	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.66e-05	0.000655	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	6.64e-05	0.000653	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	6.64e-05	0.000653	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	6.57e-05	0.000647	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	6.51e-05	0.00064	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.45e-05	0.000634	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	6.31e-05	0.000621	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.3e-05	0.00062	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	6.3e-05	0.00062	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.19e-05	0.000609	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	6.18e-05	0.000608	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	6.16e-05	0.000606	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—OPTN—amyotrophic lateral sclerosis	6.07e-05	0.000597	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	6.07e-05	0.000597	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	6.01e-05	0.000591	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.86e-05	0.000576	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.86e-05	0.000576	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.86e-05	0.000576	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.86e-05	0.000576	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.83e-05	0.000574	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	5.77e-05	0.000568	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.75e-05	0.000566	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	5.73e-05	0.000564	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	5.73e-05	0.000564	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.66e-05	0.000557	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.66e-05	0.000557	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.66e-05	0.000557	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	5.64e-05	0.000555	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.58e-05	0.000549	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	5.53e-05	0.000544	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	5.53e-05	0.000544	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.52e-05	0.000543	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.48e-05	0.000539	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.48e-05	0.000539	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	5.44e-05	0.000535	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.41e-05	0.000532	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.36e-05	0.000527	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.36e-05	0.000527	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	5.36e-05	0.000527	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	5.26e-05	0.000517	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	5.24e-05	0.000515	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	5.23e-05	0.000514	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.22e-05	0.000514	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.22e-05	0.000514	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.18e-05	0.000509	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	5.16e-05	0.000508	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	5.14e-05	0.000506	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	5.06e-05	0.000498	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.05e-05	0.000497	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.04e-05	0.000496	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	4.93e-05	0.000485	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.88e-05	0.000481	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.88e-05	0.00048	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.81e-05	0.000473	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.81e-05	0.000473	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.78e-05	0.00047	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	4.7e-05	0.000463	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	4.69e-05	0.000461	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.68e-05	0.00046	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.51e-05	0.000444	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—VAPB—amyotrophic lateral sclerosis	4.48e-05	0.000441	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TPK1—amyotrophic lateral sclerosis	4.48e-05	0.000441	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.4e-05	0.000433	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.4e-05	0.000433	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.34e-05	0.000427	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	4.3e-05	0.000423	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.29e-05	0.000422	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	4.26e-05	0.000419	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	4.23e-05	0.000416	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	4.23e-05	0.000416	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	4.21e-05	0.000414	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	4.19e-05	0.000412	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.18e-05	0.000411	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—VAPA—amyotrophic lateral sclerosis	4.1e-05	0.000404	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	4.09e-05	0.000402	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.98e-05	0.000391	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.98e-05	0.000391	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.96e-05	0.000389	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.92e-05	0.000386	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.9e-05	0.000383	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.89e-05	0.000383	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.87e-05	0.000381	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.81e-05	0.000375	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.71e-05	0.000365	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—FIG4—amyotrophic lateral sclerosis	3.59e-05	0.000353	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.56e-05	0.00035	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.54e-05	0.000349	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.47e-05	0.000342	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	3.37e-05	0.000332	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.36e-05	0.00033	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.31e-05	0.000325	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—DAO—amyotrophic lateral sclerosis	3.24e-05	0.000319	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.2e-05	0.000315	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.18e-05	0.000313	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.15e-05	0.000309	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.14e-05	0.000309	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.11e-05	0.000306	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.01e-05	0.000296	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.01e-05	0.000296	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	2.98e-05	0.000293	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	2.93e-05	0.000288	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.91e-05	0.000286	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	2.84e-05	0.00028	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.81e-05	0.000276	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.79e-05	0.000274	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.79e-05	0.000274	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.76e-05	0.000271	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.71e-05	0.000267	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.68e-05	0.000263	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.67e-05	0.000263	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.67e-05	0.000263	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.65e-05	0.000261	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.61e-05	0.000257	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.57e-05	0.000253	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.56e-05	0.000252	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.55e-05	0.000251	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.47e-05	0.000243	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.47e-05	0.000243	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	2.46e-05	0.000242	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.44e-05	0.00024	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.41e-05	0.000237	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.38e-05	0.000234	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.37e-05	0.000233	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	2.27e-05	0.000223	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.26e-05	0.000222	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.23e-05	0.000219	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.23e-05	0.000219	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.2e-05	0.000217	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	2.18e-05	0.000214	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.13e-05	0.00021	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	2.08e-05	0.000205	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.07e-05	0.000203	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000203	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.02e-05	0.000198	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2e-05	0.000197	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2e-05	0.000197	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	1.86e-05	0.000183	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	1.83e-05	0.00018	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.79e-05	0.000176	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.79e-05	0.000176	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	1.76e-05	0.000174	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.74e-05	0.000171	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	1.73e-05	0.00017	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	1.73e-05	0.00017	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.73e-05	0.00017	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.73e-05	0.00017	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.73e-05	0.00017	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.7e-05	0.000167	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.7e-05	0.000167	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.67e-05	0.000165	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.000164	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.65e-05	0.000162	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.64e-05	0.000161	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.61e-05	0.000159	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	1.6e-05	0.000157	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	1.58e-05	0.000156	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.57e-05	0.000155	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.53e-05	0.00015	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	1.52e-05	0.00015	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.51e-05	0.000148	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.51e-05	0.000148	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.5e-05	0.000147	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.47e-05	0.000145	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.47e-05	0.000144	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	1.45e-05	0.000142	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.41e-05	0.000139	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000137	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	1.38e-05	0.000136	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.38e-05	0.000136	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.34e-05	0.000132	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.34e-05	0.000132	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.34e-05	0.000132	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.31e-05	0.000129	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.28e-05	0.000126	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.25e-05	0.000123	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.25e-05	0.000123	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	1.23e-05	0.000121	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000119	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.21e-05	0.000119	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.2e-05	0.000118	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.19e-05	0.000117	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.16e-05	0.000115	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.16e-05	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000112	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.13e-05	0.000111	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.1e-05	0.000108	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.09e-05	0.000107	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—amyotrophic lateral sclerosis	1.05e-05	0.000103	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.01e-05	9.95e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1e-05	9.85e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	9.49e-06	9.33e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	9.38e-06	9.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.29e-06	9.14e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.29e-06	9.14e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.2e-06	9.05e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	8.76e-06	8.61e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	8.71e-06	8.56e-05	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	8.69e-06	8.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.5e-06	8.36e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	8.3e-06	8.17e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.26e-06	8.13e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.97e-06	7.84e-05	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—amyotrophic lateral sclerosis	7.95e-06	7.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.9e-06	7.77e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.82e-06	7.7e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	7.63e-06	7.5e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	7.57e-06	7.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.43e-06	7.31e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.39e-06	7.27e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	7.19e-06	7.07e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.72e-06	6.62e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.72e-06	6.61e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.56e-06	6.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.26e-06	6.16e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.23e-06	6.13e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.18e-06	6.08e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.72e-06	5.63e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.58e-06	5.49e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.19e-06	5.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.09e-06	5.01e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	5.08e-06	5e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	4.71e-06	4.63e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.7e-06	4.62e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.5e-06	4.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.46e-06	4.39e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.1e-06	4.03e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.86e-06	3.8e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.86e-06	3.8e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.55e-06	3.49e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.48e-06	3.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.37e-06	3.32e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-06	3.31e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.23e-06	3.17e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.09e-06	3.04e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.92e-06	2.87e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.55e-06	2.5e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.31e-06	2.27e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.07e-06	2.04e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2e-06	1.97e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.91e-06	1.88e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.74e-06	1.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.57e-06	1.54e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-06	1.06e-05	CbGpPWpGaD
